NHS England wants wearable devices tracking the vital signs of at-risk patients at home, part of a strategy to prevent 1,000 sepsis deaths a year by 2035.
Home Monitoring Enters The Sepsis Fight As NHS Sets 2035 Target
A condition that kills within hours does not wait for a scheduled clinical review, and that mismatch between how fast sepsis progresses and how slowly the system normally notices it is precisely what NHS England’s new strategy is designed to close. Roughly 4,000 people in England die from sepsis each year, with the UK Sepsis Trust putting the wider figure, including cases where sepsis contributed to death without being the primary cause, at around 48,000.
The plan announced this week commits the health service to preventing 1,000 of those deaths annually by 2035, and wearable monitoring sits at the centre of how it intends to get there.
The Mechanics Of The Rollout
Patients judged to be at elevated risk, including those on immunosuppressants, older adults, people with catheters, and those living with serious mental illness, will be offered watches, bracelets, or phone-linked monitoring that tracks blood pressure and heart rate continuously.
The logic is straightforward even if the delivery is not, catch the physiological signature of deterioration before a patient or carer notices anything is wrong, and get them tested and treated before the infection progresses. NHS data puts emergency sepsis admissions at more than 118,000 in 2024/25, which gives some sense of the population this eventually needs to reach if it is to move beyond a pilot.
None of this is being built from a blank page. It sits alongside a Manchester NHS trust’s £11 million push to bring wearable remote monitoring into community care, part of a wider cluster of public and commercial investment aimed at exactly this kind of continuous physiological tracking. Taken together, the two programmes point toward the same underlying shift, NHS England is treating wearable vital-signs monitoring as core clinical infrastructure rather than a novelty add-on to virtual care.
Why The Clock Is The Whole Story
Professor Ramani Moonesinghe, NHS England’s deputy medical director, framed early detection as the single determining factor in survival and full recovery from sepsis. That is not rhetorical flourish. For every hour that treatment is delayed, the risk of death rises by up to 8 per cent, a gradient steep enough that shaving even a few hours off the average time to treatment could plausibly account for a meaningful share of the deaths this strategy is aiming to prevent.
That timing pressure is also what separates this from the remote monitoring already embedded in virtual wards expanding their capacity to run around the clock, where monitoring already tracks blood pressure, oxygen saturation, pulse and temperature for patients recovering from acute episodes at home.
But virtual ward patients are already inside a clinical pathway, checked in, expected, accounted for. Sepsis risk patients are not. They are going about ordinary life until a wearable decides otherwise, which makes the alerting model closer to the digital triage kiosks now live across NHS Greater Glasgow and Clyde’s emergency departments, where structured data reaches clinical staff before a patient has even been formally seen.
The Precedent Already Running At UCLH
University College London Hospitals offers the clearest working example of what a mature version of this looks like. Cancer patients receiving CAR T-cell therapy there wear a chest-based device tracking heart rate, respiratory rate and temperature, built to catch both sepsis and cytokine release syndrome, a condition with overlapping symptoms that can be difficult to distinguish clinically. When the device flags concern, a rapid clinical review follows, with antibiotics administered where warranted. It is a tightly scoped cohort with an existing specialist team on standby. Scaling that same logic to a broad, dispersed population of at-risk patients living independently is a materially different operational problem, and it is one the strategy does not yet appear to have fully answered.
The Question Nobody Has Priced In Yet
Every version of ambient monitoring eventually runs into the same bottleneck, who reviews the alert, and how fast. CQC’s answer to that question keeps landing on the same two conditions regardless of which technology is involved, human oversight and demonstrable governance. A wearable that flags deterioration is only as useful as the clinical capacity sitting behind it. If thousands of at-risk patients begin generating continuous data streams, someone, primary care, community nursing, or a centralised monitoring hub, has to own triage of those alerts without drowning in false positives. NHS England has not yet said who that will be, and ICBs weighing where the funding and staffing responsibility lands will want that answered well before this moves past trial sites.
The Martha’s Rule Backdrop
The strategy is explicitly framed as building on Martha’s Rule, the escalation right introduced after the death of thirteen-year-old Martha Mills from sepsis following failings in her care at King’s College Hospital in 2021. Her parents, Merope Mills and Paul Laity, campaigned for a mechanism giving patients, families, and staff the right to demand an urgent second opinion. In its first eighteen months to February 2026, helplines under that scheme received over 12,000 calls, more than a fifth of which changed the course of a patient’s care. Minister for patient safety Preet Gill described the shift as one driven by families who turned devastating loss into structural change. Dr Ron Daniels, founder of the UK Sepsis Trust, called the new blueprint a significant step forward for patient safety.
